1 ANNEX Watch list of substances for Union-wide monitoring as set out in Article 8b of Directive 2008/105/EC, Decision_act (EU) 2025/439

In forcesince 28 Feb 2025

[Not available for all substances] [All substances shall be monitored in whole water samples.] [Extraction methods: SPE – solid-phase extraction Analytical methods: HPLC-MS/MS– High-performance liquid chromatography (tandem) triple quadrupole mass spectrometry LC-MS/MS – Liquid chromatography (tandem) triple quadrupole mass spectrometry LC-ESI-MS/MS – Liquid chromatography (tandem) triple quadrupole mass spectrometry with positive electrospray ionisation LC-QTOF-HRMS – Liquid chromatography quadrupole time-of-flight high-resolution mass spectrometry UHPLC-MS/MS – Ultra-high-performance liquid chromatography (tandem) triple quadrupole mass spectrometry] [Metformin and guanylurea shall be analysed together in the same samples but reported as individual concentrations.] [The sunscreen agents shall be analysed together in the same samples but reported as individual concentrations.] [6PPD and 6PPD-quinone shall be analysed together in the same samples but reported as individual concentrations] [The two major components of abamectin (B1a and B1b) shall be analysed together in the same samples and reported as a sum concentration.] [The azole compounds shall be analysed together in the same samples but reported as individual concentrations.] [Oxytetracycline and tetracycline shall be analysed together in the same samples but reported as individual concentrations.]

Name of substance/group of substances | Chemical Abstracts Service (CAS) number | European Community (EC) number | Indicative analytical method, | Maximum acceptable method quantification limit (ng/l)

Fipronil | 120068-37-3 | 424-610-5 | SPE-HPLC-MS/MS | 0,77

Clindamycin | 18323-44-9 | 242-209-1 | SPE-LC-MS/MS | 44

Ofloxacin | 82419-36-1 | 680-263-1 | SPE-UHPLC-MS/MS | 26

Metformin and

Guanylurea

657-24-9

141-83-3

211-517-8

205-504-6

SPE-LC-MS/MS |

156000

100000

Sunscreen agents

Butyl methoxydibenzoyl-methane

Octocrylene

Benzophenone-3

Octisalate (2-ethylhexyl salicylate)

70356-09-1

6197-30-4

131-57-7

118-60-5

274-581-6

228-250-8

205-031-5

204-263-4

SPE-LC-ESI-MS/MS |

3000

266

670

168

N-1,3-Dimethylbutyl-N’-phenyl-p-phenylenediamine (6PPD) and

6PPD-quinone

793-24-8

2754428-18-5

212-344-0

893-269-6

SPE-LC-MS/MS | 370

Abamectin

Avermectin B1a and

Avermectin B1b

71751-41-2

65195-55-3

65195-56-4

265-610-3

265-611-9

SPE-LC-MS/MS | 1

Azole compounds

Bromuconazole

Climbazole

Cyazofamid

Difenoconazole

Epoxiconazole

Itraconazole

Ketoconazole

Mefentrifluconazole

Propiconazole

Triticonazole

116255-48-2

38083-17-9

120116-88-3

119446-68-3

133855-98-8

84625-61-6

65277-42-1

1417782-03-6

60207-90-1

131983-72-7

408-060-3

253-775-4

601-671-8

601-613-1

406-850-2

617-596-9

265-667-4

822-682-6

262-104-4

603-543-7

SPE-LC-MS/MS |

15

110

130

360

180

8

50

1600

1000

1000

Etoxazole | 153233-91-1 | 604-891-2 | SPE-GC-MS/MS | 0,4

Fluoxetine | 54910-89-3 | 611-209-7 | SPE-LC-QTOF-HRMS | 12

Propranolol | 525-66-6 | 208-378-0 | SPE-LC-MS/MS | 20

Oxytetracycline and

Tetracycline

79-57-2

60-54-8

201-212-8

200-481-9

SPE-LC-MS/MS |

500

90